PureTech Health (LON:PRTC) Insider Michele Holcomb Buys 29,239 Shares

PureTech Health plc (LON:PRTC) insider Michele Holcomb purchased 29,239 shares of the stock in a transaction that occurred on Tuesday, September 23rd. The stock was bought at an average price of GBX 125 per share, with a total value of £36,548.75.

PureTech Health Price Performance

PRTC opened at GBX 126.80 on Thursday. PureTech Health plc has a 1 year low of GBX 100.40 and a 1 year high of GBX 178. The firm has a market capitalization of £306.46 million, a PE ratio of 745.88 and a beta of 1.02. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51. The business’s 50-day moving average is GBX 128.95 and its two-hundred day moving average is GBX 129.60.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.